Skip to main content
LXRX logo

LXRX · Lexicon Pharmaceuticals, Inc. · Short Interest

Track LXRX — free
$1.79 -0.03 (-1.65%) At close · Nov 13 Play latest call Q3 2026 earnings call transcript
Market Cap
$796.97M
Shares
445.23M
Volume · Nov 13 1.89M Avg daily vol (3M) 2.62M

Shares sold short and not yet covered, reported twice monthly. Days to cover is the reported short position divided by average daily volume.

LXRX Latest Reported Short Interest

FINRA reported 25,877,882 LXRX shares sold short as of the October 30, 2026 settlement date, a decrease of 826,050 shares. Days to cover was 14.04 based on FINRA's reported average daily volume.

Official FINRA short-interest data · share counts are restated for subsequent splits of this listing

LXRX Short Interest Forecast

Equibles' model estimates 26,074,775 shares sold short for the November 13, 2026 settlement, +0.8% versus the latest reported position, with a likely range of 23,884,587 to 28,285,461 shares. This model prediction uses FINRA data through November 13, 2026; FINRA's official release is expected November 24, 2026.

Model estimate

Expected Nov 13 short interest

as of Nov 13 Low confidence 47% chance it rises
26,074,775 +0.8% vs reported
Likely range 23,884,587 to 28,285,461 The latest estimate appears in the chart below. Official release expected Nov 24. Methodology
Short Squeeze Score
69/100
Short interest 5.8% of shares — P75 Days to cover 14.0 — P94 Price vs VWAP -6.9% — P45 Short-volume trend +9.3% — P83 Short interest change -3.1% — P42 Worst FTD 0.00% of shares — P37

Positioning score 68.6 + catalyst boost 0 (total capped at 100). This is a screening index, not a probability of a squeeze.

Method and coverage limits

Factor percentiles compare eligible primary operating-company stocks reporting short interest at the latest settlement date (2026-10-30). The weighted mean uses short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, and fails-to-deliver 10%. Missing factors redistribute their weight; incomplete coverage is not evidence of low risk. Price, volume, and earnings boosts add 10 each, capped at 20.

Shares outstanding are not free float. Borrow fees, utilization, lendable supply, recalls, and dealer inventory are not measured. Short-sale volume does not measure the change in open shorts; fails to deliver are not a borrow-cost measurement; price vs VWAP does not establish short sellers' entry prices. Earnings can move prices in either direction.

The weights are judgment-based, not calibrated to future squeeze outcomes. The separate options assessment below does not change this universe ranking.

Options positioning & squeeze sensitivity

Nearest expiration after today within 30 calendar days; same-day expirations and later maturities are excluded.

Open interest is incomplete, stale, or dated inconsistently; positioning totals are unavailable.

Open interest has both a buyer and a seller; it does not reveal dealer hedge direction. Gross gamma sums both calls and puts without netting and uses a local 1% price-change approximation. It measures sensitivity, not predicted buying or a squeeze probability.

Assessment prepared 2026-11-15 12:05 UTC. Options model values may come from a cached snapshot; their original computation time is not supplied. Open interest has its own effective date.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-11-30 Scheduled
FINRA publishes Dec 9
— — — —
2026-11-13 Scheduled
FINRA publishes Nov 24
— — — —
2026-10-30 25,877,882 26,703,932 -826,050 14.04
2026-10-15 26,703,932 25,828,112 +875,820 12.97
2026-09-30 25,828,112 28,793,507 -2,965,395 6.16
2026-09-15 28,793,507 29,490,809 -697,302 13.40
2026-08-31 29,490,809 32,749,669 -3,258,860 10.28
2026-08-14 32,749,669 32,825,365 -75,696 10.93
2026-07-31 32,825,365 32,730,919 +94,446 12.46
2026-07-15 32,730,919 30,784,601 +1,946,318 12.03
2026-06-30 30,784,601 25,425,636 +5,358,965 4.44
2026-06-15 25,425,636 26,206,147 -780,511 12.62
2026-05-29 26,206,147 26,140,915 +65,232 13.74
2026-05-15 26,140,915 23,857,393 +2,283,522 6.22
2026-04-30 23,857,393 23,674,019 +183,374 13.59
2026-04-15 23,674,019 22,932,295 +741,724 11.62
2026-03-31 22,932,295 22,693,812 +238,483 9.07
2026-03-13 22,693,812 23,139,559 -445,747 7.14
2026-02-27 23,139,559 24,523,367 -1,383,808 12.65
2026-02-13 24,523,367 24,583,755 -60,388 8.57
2026-01-30 24,583,755 25,160,782 -577,027 4.69
2026-01-15 25,160,782 23,660,410 +1,500,372 17.95
2025-12-31 23,660,410 23,344,944 +315,466 12.34
2025-12-15 23,344,944 24,226,907 -881,963 16.82
2025-11-28 24,226,907 24,649,659 -422,752 16.97

Full FINRA short interest reporting calendar

Showing 1–23 of 23 settlements
Key facts CIK 1062822 CUSIP 528872302 13F (30d) 122 filings 108 filers Visit website Investor relations